Murfreesboro-based National HealthCare Corp. will break ground this week on a 112-bed skilled nursing center in Maury County.
The new Columbia facility is a joint venture between NHC and Maury Regional Medical Center and represents an $18 million investment. Last October, NHC began work on a similar facility in Bellevue. NHC Place at the Trace is expected to open next spring.
Shares of NHC (Ticker: NHC) were $62.80 Monday afternoon. Year to date, they're flat.
Under CEO Justin Hutchens, senior living real estate investment trust National Health Investors has tripled its asset base to about $2 billion while its market cap now stands at more than $2.3 billion. In a recent interview with Senior Housing News, Hutchens discusses some of the ways he plans to further build NHI's footprint. California looks to be a key growth market thanks to its tighter regulations but Texas and Florida likely won't figure as prominently because their barriers to entry are lower.
Read the full Q&A here.
Ronald Orol at The Street says activist investor Sandell Asset Management appears to hold a strong hand in its dealings with Brookdale Senior Living, which it wants to spin off its real estate. The New York-based investment firm, Orol writes, plans to add to its board presence next spring to try to force such a transaction unless Brookdale's directors act before then. And the pieces are in place for such action — as are two deep-pocketed potential buyers.
For HCP and Ventas, an acquisition of Brookdale or its assets would prevent the formation of a new rival. Any move by Brookdale to spin off its massive real estate holdings into a free-standing REIT would create new competition for HCP and Ventas in the health care REIT industry, people familiar with Sandell argue.
Goldman Sachs analyst Brian Zimmerman has begun covering shares of Brookdale Senior Living with a 'buy' rating. He sees the stock, which closed at $36.87 (Ticker: BKD) and is flat year to date, climbing to $45 in the coming year. Among the seven analysts tracking the Brentwood-based company, the median price target is $44.